M. Marcq

1.2k total citations
28 papers, 197 citations indexed

About

M. Marcq is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, M. Marcq has authored 28 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in M. Marcq's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). M. Marcq is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). M. Marcq collaborates with scholars based in France, Greece and Japan. M. Marcq's co-authors include A Minette, L. Cellerin, Marc G. Denis, C. Chouaïd, Radj Gervais, Christine Sagan, Audrey Vallée, J.B. Auliac, Florian Guisier and Catherine Dubos‐Arvis and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Annals of Oncology.

In The Last Decade

M. Marcq

25 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Marcq France	9	148	87	30	26	22	28	197
J.R. Jarabo Spain	8	77 0.5×	92 1.1×	37 1.2×	25 1.0×	49 2.2×	20	187
Norihito Omote Japan	9	129 0.9×	51 0.6×	24 0.8×	58 2.2×	73 3.3×	20	226
Rüveyda Ayasun United States	6	66 0.4×	57 0.7×	44 1.5×	24 0.9×	47 2.1×	10	165
I. Majer Slovakia	8	104 0.7×	26 0.3×	33 1.1×	42 1.6×	45 2.0×	14	165
Yasunari Ubukata Japan	9	92 0.6×	105 1.2×	21 0.7×	24 0.9×	46 2.1×	33	220
Yuya Shirai Japan	5	54 0.4×	89 1.0×	101 3.4×	8 0.3×	17 0.8×	14	196
Seishi Orii Japan	11	79 0.5×	81 0.9×	7 0.2×	55 2.1×	35 1.6×	33	281
Devalben Patel Canada	10	176 1.2×	82 0.9×	10 0.3×	68 2.6×	78 3.5×	35	292
Zamir Kadija Italy	11	280 1.9×	27 0.3×	33 1.1×	26 1.0×	56 2.5×	19	374
Sanjeev Deva New Zealand	9	60 0.4×	179 2.1×	15 0.5×	29 1.1×	64 2.9×	37	249

Countries citing papers authored by M. Marcq

Since Specialization

Citations

This map shows the geographic impact of M. Marcq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Marcq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Marcq more than expected).

Fields of papers citing papers by M. Marcq

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Marcq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Marcq. The network helps show where M. Marcq may publish in the future.

Co-authorship network of co-authors of M. Marcq

This figure shows the co-authorship network connecting the top 25 collaborators of M. Marcq. A scholar is included among the top collaborators of M. Marcq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Marcq. M. Marcq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garrido, Pilar, et al.. (2025). 13P: Brain metastases and actionable genetic alterations with sacituzumab govitecan versus docetaxel in metastatic non-small cell lung cancer: Subgroups of the phase III EVOKE-01 trial. Journal of Thoracic Oncology. 20(3). S17–S18.

Molinier, Olivier, M. Marcq, Philippe Masson, et al.. (2023). A Comparative Multicenter Cohort Study Evaluating the Long-Term Influence of the Strict Lockdown during the First COVID-19 Wave on Lung Cancer Patients (ARTEMISIA Trial). Cancers. 15(24). 5729–5729. 1 indexed citations

Denis, Marc G., Christine Sagan, Audrey Vallée, et al.. (2023). 1359P Relationship between tumor TP53 gene mutation, circulating anti-p53 antibodies and response to first-line osimertinib in EGFR-mutated NSCLC patients. Annals of Oncology. 34. S781–S781. 1 indexed citations

Descourt, R., Laurent Greillier, M. Pérol, et al.. (2022). First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study). Cancer Immunology Immunotherapy. 72(1). 91–99. 18 indexed citations

Descourt, R., Laurent Greillier, M. Pérol, et al.. (2021). First-line pembrolizumab monotherapy for PD-L1-positive (TPS ≥ 50%) advanced non-small cell lung cancer (aNSCLC) in the real world: A national French bispective multicentric cohort—ESCKEYP trial (GFPC 05-2018).. Journal of Clinical Oncology. 39(15_suppl). 9091–9091. 2 indexed citations

Bennouna, Jaafar, Nicolas Girard, Clarisse Audigier-Valette, et al.. (2019). Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial. Clinical Lung Cancer. 21(1). e10–e14. 19 indexed citations

Auliac, J.B., G François, Henri Janicot, et al.. (2018). Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors. Targeted Oncology. 13(4). 501–507. 35 indexed citations

Tison, Alice, Gilles Quéré, L. Misery, et al.. (2018). OP0196 Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune diseases: a nationwide multicenter retrospective study. Annals of the Rheumatic Diseases. 77. 147–147. 6 indexed citations

Marcq, M., et al.. (2014). Detection of EGFR Mutations in the Plasma of Patients with Lung Adenocarcinoma for Real-Time Monitoring of Therapeutic Response to Tyrosine Kinase Inhibitors?. Journal of Thoracic Oncology. 9(7). e49–e50. 17 indexed citations

10.

Bourgeois, Hugues, Philippe Solal‐Céligny, Olivier Capitain, et al.. (2014). Assessing 2-month clinical prognosis in patients with solid tumors: Final results of PRONOPALL study.. Journal of Clinical Oncology. 32(15_suppl). 9558–9558. 1 indexed citations

11.

Bourgeois, Hugues, S Traoré, Philippe Solal‐Céligny, et al.. (2011). Assessing 2-month clinical prognosis in patients with solid tumors: First results of PRONOPALL study.. Journal of Clinical Oncology. 29(15_suppl). 6047–6047. 1 indexed citations

12.

Marcq, M., et al.. (2008). L’hémorragie intra-alvéolaire, une complication rare du syndrome primaire des antiphospholipides. La Revue de Médecine Interne. 30(3). 271–273. 7 indexed citations

13.

Cellerin, L., M. Marcq, Christine Sagan, & Emmanuel Chailleux. (2008). Pleurésies malignes révélatrices d’un cancer : comparaison des étiologies avec les pleurésies métastatiques d’un cancer connu. Revue des Maladies Respiratoires. 25(9). 1104–1109. 10 indexed citations

14.

Marcq, M., et al.. (2007). Une maladie de Carrington sans éosinophilie au lavage broncho-alvéolaire: Pneumopathie chronique à éosinophiles. Revue des Maladies Respiratoires. 24(7). 896–899. 3 indexed citations

15.

Marcq, M., et al.. (2007). Une maladie de Carrington sans éosinophilie au lavage broncho-alvéolaire. Revue des Maladies Respiratoires. 24(7). 896–899. 4 indexed citations

16.

Ebstein, Frédéric, Pierre‐Joseph Royer, M. Marcq, et al.. (2004). Cytotoxic T Cell Responses against Mesothelioma by Apoptotic Cell-pulsed Dendritic Cells. American Journal of Respiratory and Critical Care Medicine. 169(12). 1322–1330. 20 indexed citations

17.

Marcq, M., P. Germaud, L. Cellerin, Christine Sagan, & Emmanuel Chailleux. (2004). Aspergilloses respiratoires complexes : difficultés diagnostiques et thérapeutiques. Revue des Maladies Respiratoires. 21(6). 1162–1166. 4 indexed citations

18.

Minette, A & M. Marcq. (1979). Oxitropium bromide (Ba 253), an advance in the field of anticholinergic bronchodilating treatments. Preliminary results.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 34(3). 115–23. 11 indexed citations

19.

Minette, A, et al.. (1978). Prognostic value of a positive acetylcholine test regarding VC and FEV1 in coal-miners with a history of chronic bronchitis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(2). 167–75. 10 indexed citations

20.

Marcq, M., et al.. (1967). A study of the mechanism of ethacrynic acid induced hyperglycemia.. PubMed. 12(2). 160–2. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact